Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Xo Biologix
FDA Inspection
•Xo Biologix•January 5, 2024

Xo Biologix – FDA Inspection, Jan 5, 2024

Record Details

This FDA Inspection record concerns Xo Biologix, with an inspection on January 5, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company
Xo Biologix
Inspection Date
January 5, 2024
Product Type
Biologics
Office
Center for Biologics Evaluation and Research
People
  • Bobbi J. Miller
  • Richard T. Riggie (Company Rep)
View Company Profile

ID · 5ca24396-47bf-452b-963b-7e96d00153fb

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1226827
FDA center
Biologics
Project area
Human Cellular, Tissue, and Gene Therapies
Enforcement
Warning Letter

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Xo Biologix
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.